CN113046398A - Fermentation method for stably and efficiently producing L-isoleucine and fermentation stabilizer - Google Patents
Fermentation method for stably and efficiently producing L-isoleucine and fermentation stabilizer Download PDFInfo
- Publication number
- CN113046398A CN113046398A CN202110539756.3A CN202110539756A CN113046398A CN 113046398 A CN113046398 A CN 113046398A CN 202110539756 A CN202110539756 A CN 202110539756A CN 113046398 A CN113046398 A CN 113046398A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- isoleucine
- stabilizer
- stably
- efficiently producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 150
- 230000004151 fermentation Effects 0.000 title claims abstract description 150
- 239000003381 stabilizer Substances 0.000 title claims abstract description 41
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 title claims abstract description 39
- 229960000310 isoleucine Drugs 0.000 title claims abstract description 38
- 229930182844 L-isoleucine Natural products 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 23
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 38
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 36
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims abstract description 19
- 235000019743 Choline chloride Nutrition 0.000 claims abstract description 19
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims abstract description 19
- 229960003178 choline chloride Drugs 0.000 claims abstract description 19
- 235000008160 pyridoxine Nutrition 0.000 claims abstract description 19
- 239000011677 pyridoxine Substances 0.000 claims abstract description 19
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 19
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 18
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 18
- 229960000304 folic acid Drugs 0.000 claims abstract description 18
- 235000019152 folic acid Nutrition 0.000 claims abstract description 18
- 239000011724 folic acid Substances 0.000 claims abstract description 18
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 16
- 240000008042 Zea mays Species 0.000 claims description 26
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 26
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 26
- 235000005822 corn Nutrition 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000008367 deionised water Substances 0.000 claims description 14
- 229910021641 deionized water Inorganic materials 0.000 claims description 14
- 239000000413 hydrolysate Substances 0.000 claims description 6
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 28
- 239000002253 acid Substances 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 7
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 235000015097 nutrients Nutrition 0.000 abstract description 5
- 238000009776 industrial production Methods 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 25
- 238000002474 experimental method Methods 0.000 description 23
- 238000004128 high performance liquid chromatography Methods 0.000 description 14
- 239000007788 liquid Substances 0.000 description 13
- 239000002609 medium Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 241000186226 Corynebacterium glutamicum Species 0.000 description 11
- 239000002054 inoculum Substances 0.000 description 11
- 230000001502 supplementing effect Effects 0.000 description 11
- 230000008569 process Effects 0.000 description 6
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- WXYIONYJZVWSIJ-UHFFFAOYSA-N acetonitrile;methanol;hydrate Chemical compound O.OC.CC#N WXYIONYJZVWSIJ-UHFFFAOYSA-N 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
Abstract
The invention discloses a fermentation method and a fermentation stabilizer for stably and efficiently producing L-isoleucine, wherein 0.8-1.2mL of fermentation stabilizer is supplemented to 1L of fermentation liquor once every 1h during 22-42h of fermentation, and each liter of fermentation stabilizer contains 2-4g of cobalamin, 1-3g of pyridoxine, 1-3g of choline chloride and 2-4g of folic acid, so that key nutrients which are actually lacked and are important to the anabolism of L-isoleucine are compensated after the fluctuation of a nitrogen source, the yield is increased, the aim of stable production is fulfilled, and the stability of an acid production level is increased; the acid production by horizontal fermentation of a 50L tank can stably reach more than 48.0 g/L. The method is simple and easy to implement, has low investment but remarkable effect, does not need to add any additional equipment or manpower input, and is suitable for large-scale industrial production.
Description
The technical field is as follows:
the invention relates to the technical field of L-isoleucine fermentation, in particular to a fermentation method for stably and efficiently producing L-isoleucine and a fermentation stabilizer.
Background art:
l-isoleucine, also known as L-isoleucine, belongs to Branched Chain Amino Acids (BCAA), has various physiological functions, is a raw material for synthesizing human hormones and enzymes, has the effects of promoting protein production and inhibiting protein decomposition, and has wide application and commercial value in the food and medicine industries.
At present, a plurality of enterprises in China have produced L-isoleucine by fermentation methods, and laboratories in various colleges and universities are also developing the research subject of L-isoleucine fermentation processes. In the existing L-isoleucine fermentation process, corn steep liquor, hydrolysate or bean cake powder and the like are often used as main nitrogen sources. 10g/L corn steep liquor in the fermentation medium as disclosed in patent CN 201910980511; the patent CN201910134832 discloses that the fermentation medium contains soybean meal hydrolysate. The nitrogen source has a wide application in the field of fermentation because of its rich nutrition, relatively low cost and readily available raw materials, but it has a disadvantage of poor quality stability. Taking corn steep liquor as an example, the corn steep liquor is a concentrated solution of a soaking solution obtained by soaking corn with sulfurous acid, contains abundant amino acids, reducing sugar, organic acid, phosphorus, trace elements and growth factors, and is influenced by differences in production places, seasons, soaking processes and the like of raw materials, and the nutritional composition of the corn steep liquor has large fluctuation, so that the acid production level is large fluctuation. Often, at this moment, technical staff adopts the mode of increasing main nitrogen source quantity, or adding other more stable nitrogen sources to improve, and the result has increased the auxiliary material cost on the one hand, and on the other hand probably because the increase of feed liquid nutrient substance concentration, the thallus growth produces adverse effect in the early stage of fermentation, even brings the difficulty for later stage extraction.
If substances which are really important to the anabolism of L-isoleucine in nitrogen sources such as corn steep liquor, hydrolysate or bean cake powder can be determined, the substances can be supplemented in a targeted manner, and the effect of achieving twice the result with half the effort can be achieved, but related research and reports are not available at present.
The invention content is as follows:
in order to solve the above technical problems, the first object of the present invention is to provide a fermentation method for producing L-isoleucine stably and efficiently with low investment, which is simple and easy to implement.
The second object of the present invention is to provide a fermentation stabilizer for stable and efficient production of L-isoleucine.
The first purpose of the invention is implemented by the following technical scheme: a fermentation method for stably and efficiently producing L-isoleucine is characterized in that when the yield is reduced due to the quality fluctuation of a main nitrogen source, 0.8-1.2mL of fermentation stabilizer is supplemented to 1L of fermentation liquor once every 1 hour during fermentation for 22-42 hours, and each liter of fermentation stabilizer contains 2-4g of cobalamin, 1-3g of pyridoxine, 1-3g of choline chloride, 2-4g of folic acid and the balance of deionized water.
Furthermore, the main nitrogen source is any one or the combination of more than one of corn steep liquor, corn steep liquor hydrolysate and bean cake powder.
The second purpose of the invention is implemented by the following technical scheme: a fermentation stabilizer for stably and efficiently producing L-isoleucine comprises, per liter, 2-4g of cobalamin, 1-3g of pyridoxine, 1-3g of choline chloride, 2-4g of folic acid, and the balance of deionized water.
The invention mainly aims at the fermentation production of the L-isoleucine by taking corn steep liquor, hydrolysate or bean cake powder and the like as main nitrogen sources, when the yield is reduced due to the quality fluctuation of the main nitrogen sources, by supplementing proper amount of nutrient substances which are contained in the main nitrogen sources and are important relative to the anabolism of the L-isoleucine, including cobalamin, pyridoxine, choline chloride and folic acid, the adverse effect of the quality fluctuation of the main nitrogen sources is resisted, the actually lacking key nutrients which are important relative to the anabolism of the L-isoleucine behind the quality fluctuation of the nitrogen sources are compensated, the proportion among the cobalamin, the pyridoxine, the choline chloride and the folic acid is reasonably and optimally designed, the yield is improved, and the purpose of stable production is achieved.
The invention has the advantages that:
(1) according to the method, 0.8-1.2mL of fermentation stabilizer is supplemented into 1L of fermentation liquor at intervals of 1 hour during fermentation for 22-42 hours, and each liter of fermentation stabilizer contains 2-4g of cobalamin, 1-3g of pyridoxine, 1-3g of choline chloride and 2-4g of folic acid, so that key nutrients which are actually lacked and are important to the anabolism of L-isoleucine are compensated behind the quality fluctuation of a nitrogen source, the yield is improved, the aim of stable production is fulfilled, and the stability of the acid production level is improved; the acid production by horizontal fermentation of a 50L tank can stably reach more than 48.0 g/L.
(2) The method is simple and easy to implement, has low investment but remarkable effect, does not need to add any additional equipment or manpower input, and is suitable for large-scale industrial production.
The specific implementation mode is as follows:
the present invention will be further described with reference to the following examples. It should be understood that the following examples are illustrative only and are not intended to limit the scope of the present invention. Appropriate modifications to the process parameters, which may be apparent to those skilled in the art in view of the disclosure herein, are also considered to be within the scope of this patent.
Comparative experimental example 1:
the cultured Corynebacterium glutamicum seed liquid is inoculated into a 50L fermentation tank according to the inoculum concentration of 10 percent, and the initial volume is 18L. The culture medium used by the seeds comprises: 30g/L of cane sugar, 60g/L of corn steep liquor, 1.0g/L of magnesium sulfate, 1.5g/L of dipotassium hydrogen phosphate, 0.2mL/L of defoaming agent, 1.5mg/L of biotin, 12.5 mg/L of VBs, and the balance of water. The culture medium used for fermentation comprises the following components: 50g/L glucose, 40g/L corn steep liquor, 15g/L ammonium sulfate, 1.5g/L dipotassium hydrogen phosphate, 1.0g/L magnesium sulfate, 0.2mL/L defoaming agent, 2.0g/L valine, 1.0g/L methionine, 0.1mg/L biotin, 10.2mg/L VBE and the balance of water. The fermentation conditions were: the pressure in the tank is 0.06-0.08Mpa, the ventilation quantity is 10-20L/min, the stirring is carried out at 600rpm, the temperature is 30-33 ℃, the pH value is 6.8-7.2, and the dissolved oxygen is 30-50%.
The comparative experiment example was repeated 3 times, each time using a different batch of corn steep liquor, the fermentation was completed, and the isoleucine content in the fermentation broth was determined by HPLC, with the acid production level shown in table 1 below.
Comparative experiment example 2: and (3) during fermentation for 22-42h, supplementing 1.0mL of fermentation stabilizer into 1L of fermentation liquor at intervals of 1h, wherein the fermentation stabilizer contains 3g/L of cobalamin, 2g/L of pyridoxine, and the balance of deionized water.
The cultured Corynebacterium glutamicum seed liquid is inoculated into a 50L fermentation tank according to the inoculum concentration of 10 percent, and the initial volume is 18L. The seed, the composition of the medium used for fermentation and the fermentation culture conditions were the same as those in comparative experiment example 1.
The comparative experiment example was repeated 3 times, each time using a different batch of corn steep liquor, and after fermentation, the content of L-isoleucine in the fermentation broth was determined by HPLC, and the acid production level was shown in table 1 below.
Comparative experiment example 3: fermenting for 22-42h, and supplementing 1.0mL of fermentation stabilizer once every 1h to 1L of fermentation liquor, wherein the fermentation stabilizer contains 2g/L of choline chloride, 3g/L of folic acid and the balance of deionized water.
The cultured Corynebacterium glutamicum seed liquid is inoculated into a 50L fermentation tank according to the inoculum concentration of 10 percent, and the initial volume is 18L. The seed, the composition of the medium used for fermentation and the fermentation culture conditions were the same as those in comparative experiment example 1.
The comparative experiment example was repeated 3 times, each time using a different batch of corn steep liquor, and after fermentation, the content of L-isoleucine in the fermentation broth was determined by HPLC, and the acid production level was shown in table 1 below.
Comparative experiment example 4: fermenting for 22-42h, supplementing 1.0mL of fermentation stabilizer to 1L of fermentation liquor at intervals of 1h, wherein the fermentation stabilizer contains 2g/L of pyridoxine, 2g/L of choline chloride, 3g/L of folic acid, and the balance of deionized water.
The cultured Corynebacterium glutamicum seed liquid is inoculated into a 50L fermentation tank according to the inoculum concentration of 10 percent, and the initial volume is 18L. The seed, the composition of the medium used for fermentation and the fermentation culture conditions were the same as those in comparative experiment example 1.
The comparative experiment example was repeated 3 times, each time using a different batch of corn steep liquor, and after fermentation, the content of L-isoleucine in the fermentation broth was determined by HPLC, and the acid production level was shown in table 1 below.
Comparative experiment example 5: and (3) once supplementing 1.0mL of fermentation stabilizer into 1L of fermentation liquor every 1h during fermentation for 22-42h, wherein the fermentation stabilizer contains 3g/L of cobalamin, 2g/L of pyridoxine, 2g/L of choline chloride and the balance of deionized water.
The cultured Corynebacterium glutamicum seed liquid is inoculated into a 50L fermentation tank according to the inoculum concentration of 10 percent, and the initial volume is 18L. The seed, the composition of the medium used for fermentation and the fermentation culture conditions were the same as those in comparative experiment example 1.
The comparative experiment example was repeated 3 times, each time using a different batch of corn steep liquor, and after fermentation, the content of L-isoleucine in the fermentation broth was determined by HPLC, and the acid production level was shown in table 1 below.
Comparative experiment example 6: fermenting for 22-42h, supplementing 1.0mL of fermentation stabilizer to 1L of fermentation liquor at intervals of 1h, wherein the fermentation stabilizer contains 5g/L of cobalamin, 0.5g/L of pyridoxine, 2g/L of choline chloride, 3g/L of folic acid and the balance of deionized water.
The cultured Corynebacterium glutamicum seed liquid is inoculated into a 50L fermentation tank according to the inoculum concentration of 10 percent, and the initial volume is 18L. The seed, the composition of the medium used for fermentation and the fermentation culture conditions were the same as those in comparative experiment example 1.
The comparative experiment example was repeated 3 times, each time using a different batch of corn steep liquor, and after fermentation, the content of L-isoleucine in the fermentation broth was determined by HPLC, and the acid production level was shown in table 1 below.
Comparative experiment example 7: and (3) once supplementing 1.0mL of fermentation stabilizer into 1L of fermentation liquor every 1h during fermentation for 22-42h, wherein the fermentation stabilizer contains 3g/L of cobalamin, 4.5g/L of pyridoxine, 4.5g/L of choline chloride, 3g/L of folic acid and the balance of deionized water.
The cultured Corynebacterium glutamicum seed liquid is inoculated into a 50L fermentation tank according to the inoculum concentration of 10 percent, and the initial volume is 18L. The seed, the composition of the medium used for fermentation and the fermentation culture conditions were the same as those in comparative experiment example 1.
The comparative experiment example was repeated 3 times, each time using a different batch of corn steep liquor, and after fermentation, the content of L-isoleucine in the fermentation broth was determined by HPLC, and the acid production level was shown in table 1 below.
Example 1: a fermentation method for stably and efficiently producing L-isoleucine comprises the steps of fermenting for 22-42h, supplementing 0.8mL of fermentation stabilizer to 1L of fermentation liquor at intervals of 1h, wherein the fermentation stabilizer contains 2g/L of cobalamin, 1g/L of pyridoxine, 1g/L of choline chloride, 2g/L of folic acid and the balance of deionized water;
the cultured Corynebacterium glutamicum seed liquid is inoculated into a 50L fermentation tank according to the inoculum concentration of 10 percent, and the initial volume is 18L. The seed, the composition of the medium used for fermentation and the fermentation culture conditions were the same as those in comparative experiment example 1.
This example was repeated 3 times, using different batches of corn steep liquor each time, the fermentation was completed, and the content of L-isoleucine in the fermentation broth was measured by HPLC, and the acid production level is shown in table 1 below.
Example 2: a fermentation method for stably and efficiently producing L-isoleucine comprises the steps of fermenting for 22-42h, supplementing 0.8mL of fermentation stabilizer to 1L of fermentation liquor at intervals of 1h, wherein the fermentation stabilizer contains 3g/L of cobalamin, 2g/L of pyridoxine, 2g/L of choline chloride, 3g/L of folic acid and the balance of deionized water;
the cultured Corynebacterium glutamicum seed liquid is inoculated into a 50L fermentation tank according to the inoculum concentration of 10 percent, and the initial volume is 18L. The seed, the composition of the medium used for fermentation and the fermentation culture conditions were the same as those in comparative experiment example 1.
This example was repeated 3 times, using different batches of corn steep liquor each time, the fermentation was completed, and the content of L-isoleucine in the fermentation broth was measured by HPLC, and the acid production level is shown in table 1 below.
Example 3: a fermentation method for stably and efficiently producing L-isoleucine comprises the steps of fermenting for 22-42h, supplementing 1.0mL of fermentation stabilizer to 1L of fermentation liquor at intervals of 1h, wherein the fermentation stabilizer contains 3g/L of cobalamin, 2g/L of pyridoxine, 2g/L of choline chloride, 3g/L of folic acid and the balance of deionized water;
the cultured Corynebacterium glutamicum seed liquid is inoculated into a 50L fermentation tank according to the inoculum concentration of 10 percent, and the initial volume is 18L. The seed, the composition of the medium used for fermentation and the fermentation culture conditions were the same as those in comparative experiment example 1.
This example was repeated 3 times, using different batches of corn steep liquor each time, the fermentation was completed, and the content of L-isoleucine in the fermentation broth was measured by HPLC, and the acid production level is shown in table 1 below.
Example 4: a fermentation method for stably and efficiently producing L-isoleucine comprises the steps of fermenting for 22-42h, supplementing 1.2mL of fermentation stabilizer to 1L of fermentation liquor at intervals of 1h, wherein the fermentation stabilizer contains 4g/L of cobalamin, 3g/L of pyridoxine, 3g/L of choline chloride, 4g/L of folic acid and the balance of deionized water;
the cultured Corynebacterium glutamicum seed liquid is inoculated into a 50L fermentation tank according to the inoculum concentration of 10 percent, and the initial volume is 18L. The seed, the composition of the medium used for fermentation and the fermentation culture conditions were the same as those in comparative experiment example 1.
This example was repeated 3 times, using different batches of corn steep liquor each time, the fermentation was completed, and the content of L-isoleucine in the fermentation broth was measured by HPLC, and the acid production level is shown in table 1 below.
TABLE 1 comparative index of acid production for Experimental examples 1-7 versus examples 1-4
As can be seen from Table 1, 0.8-1.2mL of fermentation stabilizer is supplemented into 1L of fermentation liquor at intervals of 1 hour during 22-42 hours of fermentation, each liter of the fermentation stabilizer contains 2-4g of cobalamin, 1-3g of pyridoxine, 1-3g of choline chloride and 2-4g of folic acid, targeted nutrition supplementation is realized, the acid production difference between different corn steep liquor batches in the same process is obviously shortened, the acid production level is improved, the fermentation cost is reduced, the 50L tank horizontal fermentation acid production is stabilized to be more than 48.0g/L, 1.0mL of fermentation stabilizer is supplemented into 1L of fermentation liquor at intervals of 1 hour during 22-42 hours of fermentation, 3g/L of cobalamin, 2g/L of pyridoxine, 2g/L of choline chloride and 3g/L of folic acid are contained in the fermentation stabilizer, the effect is most remarkable. Meanwhile, it can be seen from table 1 that the purpose of improving yield and stabilizing production can be achieved only when the components and the proportion in the fermentation stabilizer are reasonably designed.
Interpretation of terms:
1. the fermentation process comprises the following steps: the method is a whole process for accumulating a target product by utilizing microbial strains, and comprises the steps of culture medium formula and configuration, strain rejuvenation, expanding culture, control of the culture process, control of key parameters such as temperature, pH, dissolved oxygen and the like, nutrition supplement, control of culture ending and the like.
2. The existing fermentation process comprises the following steps: refers to publicly reported or widely known fermentation processes.
HPLC determination: the high performance liquid chromatography detection method is a chromatographic process using liquid under high pressure as a mobile phase. So-called column chromatography, thin layer chromatography or paper chromatography are classical liquid chromatography. The stationary phase used is an adsorbent (silica gel, alumina, etc.) of greater than 100 um. The fixed phase used by the traditional liquid chromatography has large granularity and slow mass transfer diffusion, so the column efficiency is low, the separation capability is poor, and only simple mixture separation can be carried out. The stationary phase used by the high performance liquid chromatography detection method has small granularity (5-10 um), fast mass transfer and high column efficiency.
4. The invention adopts an Agilent Technologies 1200 to detect the content of L-isoleucine accumulated in fermentation liquor, and the specific method is as follows:
4.1 column: ZORBAX Eclipse-AAA column (3.5 μm, 4.6X 75 mm).
4.2 mobile phase A: 6.24g NaH was weighed2PO4·2H2O, transferred into a 1000mL glass beaker. 1000mL of ultrapure water was added and stirred until all crystals were completely dissolved. The pH of the solution was adjusted to 7.80 with NaOH.
4.3 mobile phase B: acetonitrile methanol water 45:45:10 (V/V).
4.4 flow rate: 2 ml/min.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (3)
1. A fermentation method for stably and efficiently producing L-isoleucine is characterized by comprising the following steps: when the yield is reduced due to the quality fluctuation of a main nitrogen source, 0.8-1.2mL of fermentation stabilizer is supplemented to 1L of fermentation liquor once every 1h during fermentation for 22-42h, wherein each liter of the fermentation stabilizer contains 2-4g of cobalamin, 1-3g of pyridoxine, 1-3g of choline chloride, 2-4g of folic acid and the balance of deionized water.
2. The fermentation method for stably and efficiently producing L-isoleucine according to claim 1, wherein: the main nitrogen source is any one or the combination of more than one of corn steep liquor, corn steep liquor hydrolysate and bean cake powder.
3. A fermentation stabilizer for stably and efficiently producing L-isoleucine is characterized in that each liter of the fermentation stabilizer contains 2-4g of cobalamin, 1-3g of pyridoxine, 1-3g of choline chloride, 2-4g of folic acid and the balance of deionized water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110539756.3A CN113046398A (en) | 2021-05-18 | 2021-05-18 | Fermentation method for stably and efficiently producing L-isoleucine and fermentation stabilizer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110539756.3A CN113046398A (en) | 2021-05-18 | 2021-05-18 | Fermentation method for stably and efficiently producing L-isoleucine and fermentation stabilizer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113046398A true CN113046398A (en) | 2021-06-29 |
Family
ID=76518508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110539756.3A Pending CN113046398A (en) | 2021-05-18 | 2021-05-18 | Fermentation method for stably and efficiently producing L-isoleucine and fermentation stabilizer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113046398A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114606275A (en) * | 2022-02-11 | 2022-06-10 | 安徽丰原发酵技术工程研究有限公司 | Method for producing L-isoleucine through fermentation |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3642579A (en) * | 1965-03-06 | 1972-02-15 | Kyowa Hakko Kogyo Kk | Process for producing l-proline |
WO2007087815A2 (en) * | 2004-12-17 | 2007-08-09 | Metanomics Gmbh | Process for the control of production of fine chemicals |
CN101558163A (en) * | 2006-10-10 | 2009-10-14 | 味之素株式会社 | Method for production of L-amino acid |
EP2360263A1 (en) * | 2008-11-27 | 2011-08-24 | Ajinomoto Co., Inc. | Process for producing l-amino acid |
CN104357503A (en) * | 2014-11-23 | 2015-02-18 | 吉林大学 | Method for improving yield of isoleucine |
WO2015042550A1 (en) * | 2013-09-22 | 2015-03-26 | Lanzatech New Zealand Limited | A fermentation process |
CN104878051A (en) * | 2015-05-25 | 2015-09-02 | 天津科技大学 | Method for improving fermentation yield of L-isoleucine through adding choline |
CN105229157A (en) * | 2013-01-30 | 2016-01-06 | 赢创德固赛有限公司 | For passing through the amino acid whose microorganism of fermentative production and method |
EP3085705A1 (en) * | 2015-04-22 | 2016-10-26 | Ajinomoto Co., Inc. | A method for producing l-isoleucine using a bacterium of the family enterobacteriaceae having overexpressed the cyca gene |
CN106260662A (en) * | 2016-08-22 | 2017-01-04 | 安徽广通生物科技有限责任公司 | A kind of preparation method of enzymatic hydrolysis and fermentation type premix material |
CN106701853A (en) * | 2016-12-02 | 2017-05-24 | 武汉远大弘元股份有限公司 | Corynebacterium glutamicum fermentation culture medium and corynebacterium glutamicum fermentation culture method for producing L-isoleucine |
CN107893089A (en) * | 2016-10-03 | 2018-04-10 | 味之素株式会社 | Method for producing L amino acid |
WO2018204764A1 (en) * | 2017-05-05 | 2018-11-08 | Camp4 Therapeutics Corporation | Identification and targeted modulation of gene signaling networks |
CN109517771A (en) * | 2017-09-18 | 2019-03-26 | 赢创德固赛有限公司 | The method of fermentation producing L-amino-acid |
CN111172086A (en) * | 2020-03-18 | 2020-05-19 | 通辽梅花生物科技有限公司 | Fermentation method for producing L-isoleucine |
-
2021
- 2021-05-18 CN CN202110539756.3A patent/CN113046398A/en active Pending
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3642579A (en) * | 1965-03-06 | 1972-02-15 | Kyowa Hakko Kogyo Kk | Process for producing l-proline |
WO2007087815A2 (en) * | 2004-12-17 | 2007-08-09 | Metanomics Gmbh | Process for the control of production of fine chemicals |
CN101558163A (en) * | 2006-10-10 | 2009-10-14 | 味之素株式会社 | Method for production of L-amino acid |
EP2360263A1 (en) * | 2008-11-27 | 2011-08-24 | Ajinomoto Co., Inc. | Process for producing l-amino acid |
CN105229157A (en) * | 2013-01-30 | 2016-01-06 | 赢创德固赛有限公司 | For passing through the amino acid whose microorganism of fermentative production and method |
WO2015042550A1 (en) * | 2013-09-22 | 2015-03-26 | Lanzatech New Zealand Limited | A fermentation process |
CN104357503A (en) * | 2014-11-23 | 2015-02-18 | 吉林大学 | Method for improving yield of isoleucine |
EP3085705A1 (en) * | 2015-04-22 | 2016-10-26 | Ajinomoto Co., Inc. | A method for producing l-isoleucine using a bacterium of the family enterobacteriaceae having overexpressed the cyca gene |
CN104878051A (en) * | 2015-05-25 | 2015-09-02 | 天津科技大学 | Method for improving fermentation yield of L-isoleucine through adding choline |
CN106260662A (en) * | 2016-08-22 | 2017-01-04 | 安徽广通生物科技有限责任公司 | A kind of preparation method of enzymatic hydrolysis and fermentation type premix material |
CN107893089A (en) * | 2016-10-03 | 2018-04-10 | 味之素株式会社 | Method for producing L amino acid |
CN106701853A (en) * | 2016-12-02 | 2017-05-24 | 武汉远大弘元股份有限公司 | Corynebacterium glutamicum fermentation culture medium and corynebacterium glutamicum fermentation culture method for producing L-isoleucine |
WO2018099452A1 (en) * | 2016-12-02 | 2018-06-07 | 武汉远大弘元股份有限公司 | L-isoleucine-producing corynebacterium glutamicum fermentation medium and culture method |
WO2018204764A1 (en) * | 2017-05-05 | 2018-11-08 | Camp4 Therapeutics Corporation | Identification and targeted modulation of gene signaling networks |
CN109517771A (en) * | 2017-09-18 | 2019-03-26 | 赢创德固赛有限公司 | The method of fermentation producing L-amino-acid |
CN111172086A (en) * | 2020-03-18 | 2020-05-19 | 通辽梅花生物科技有限公司 | Fermentation method for producing L-isoleucine |
Non-Patent Citations (3)
Title |
---|
LU PENG等: "The Optimization of L-Isoleucine Fermentation Conditions by Brevibacterium fmavum KM011", 《ENLIVEN: MICROBES AND MICROBIAL TECHNIQUES》 * |
刘丽君: "L-异亮氨酸产生菌的选育及发酵条件研究", 《中国优秀硕士学位论文全文数据库》 * |
孔帅等: "微生物发酵法生产L-异亮氨酸的研究进展", 《CHINA BREWING》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114606275A (en) * | 2022-02-11 | 2022-06-10 | 安徽丰原发酵技术工程研究有限公司 | Method for producing L-isoleucine through fermentation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109504719B (en) | Method for improving acid production rate and extraction rate of glutamic acid | |
EP3550026B1 (en) | L-isoleucine-producing corynebacterium glutamicum fermentation medium and culture method | |
CN106065411B (en) | Production of creatine by fermentation method | |
CN110396493B (en) | Culture medium composition and method for producing isoleucine | |
CN111172086B (en) | Fermentation method for producing L-isoleucine | |
CN109628513B (en) | Amino acid fermentation medium and preparation method thereof | |
CN112195204B (en) | Method for producing branched chain amino acid by mixed fermentation | |
CN113046398A (en) | Fermentation method for stably and efficiently producing L-isoleucine and fermentation stabilizer | |
CN104651427A (en) | Method for preparing doramectin | |
CN112501221A (en) | Method for improving conversion rate of threonine and saccharic acid | |
CN115895976B (en) | Escherichia coli for producing L-tryptophan and application thereof in producing L-tryptophan | |
CN116024280A (en) | Method for improving tryptophan fermentation conversion rate by mixed culture | |
JPS61212249A (en) | Composition for feed | |
CN112251476B (en) | Production method of L-phenylalanine | |
CN105349590B (en) | Method for producing glutamine by microbial fermentation feeding | |
CN106701868A (en) | Culture medium for producing nosiheptide in fermentation way by using streptomyces actuosus, and material supplementing method | |
CN112029683A (en) | Glucose control process for improving L-isoleucine yield | |
CN112481325A (en) | Method for producing histidine by using serratia marcescens fed-batch glucose | |
CN111560414A (en) | Fermentation medium for producing demethylated aureomycin | |
KR100752928B1 (en) | Fermentation for preparing l-lysine | |
CN114231424B (en) | Preparation method of Acremonium terricola culture and application of Acremonium terricola culture in improving lactation of sows | |
CN111705092B (en) | Feed supplement for improving fermentation titer of spectinomycin and preparation method and use method thereof | |
CN117089586A (en) | Culture medium and method for fermentative production of compounds of formula (I) | |
CN114438145A (en) | Method for producing L-valine by fermentation | |
CN117721160A (en) | Method for improving glutamic acid yield by feeding nutrient solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210629 |